1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon-Reference-Cited by-同舟云学术

1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon

Published:2021-05 Issue:10 Volume:14 Page:1123-1133
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Sachar Ravish,Soga Yoshimitsu,Ansari Mohammad M.,Kozuki Amane,Lopez Louis,Brodmann Marianne,Schroë Herman,Ramanath Vijay S.,Diaz-Cartelle Juan,Zeller Thomas

Funder

Boston Scientific Corp

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease;Caradu;J Vasc Surg,2019

2. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs;Kayssi;Cochrane Database Syst Rev,2016

3. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and/or popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial;Tepe;Circulation,2015

4. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease;Rosenfield;N Engl J Med,2015

5. Stellarex Drug-Coated balloon for treatment of femoropopliteal disease: 12-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies;Krishnan;Circulation,2017

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bibliometric Analysis on Adherence to Reporting Standards for Endovascular Treatment of Chronic Lower Extremity Peripheral Artery Disease;Annals of Vascular Surgery;2024-12

2. Stellarex Drug-Coated Balloon for the Treatment of Peripheral Artery Disease: Five-Year Results from the ILLUMENATE Pivotal Randomized Controlled Trial;The American Journal of Cardiology;2024-09

3. Drug-eluting devices for lower limb peripheral arterial disease;EuroIntervention;2024-09

4. Impact of post-procedural peripheral fractional flow reserve after drug-coated balloon angioplasty in femoropopliteal lesions;Cardiovascular Revascularization Medicine;2024-09

5. A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions;JACC: Cardiovascular Interventions;2024-07